Evidence map›Paper›PMID 41384190›Full record

ArticleCureus2025

Pulmonary Benign Metastasizing Leiomyoma in a Patient With a Concurrent Breast Tumor: A Diagnostic Challenge.

Tomoyuki Araya, Toshiyuki Kita, Takayuki Higashi, Ryo Hara, Hazuki Takato

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Tomoyuki ArayaRespiratory Medicine, National Hospital Organization (NHO) Kanazawa Medical Center, Kanazawa, JPN.
Toshiyuki KitaRespiratory Medicine, National Hospital Organization (NHO) Kanazawa Medical Center, Kanazawa, JPN.
Takayuki HigashiRespiratory Medicine, National Hospital Organization (NHO) Kanazawa Medical Center, Kanazawa, JPN.
Ryo HaraRespiratory Medicine, National Hospital Organization (NHO) Kanazawa Medical Center, Kanazawa, JPN.
Hazuki TakatoRespiratory Medicine, National Hospital Organization (NHO) Kanazawa Medical Center, Kanazawa, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pulmonary benign metastasizing leiomyoma (PBML) is a rare condition in which histologically benign smooth muscle tumors occur in distant organs, most often the lungs. Although typically discovered incidentally, differentiating BML from metastatic malignancy can be challenging in real-world clinical settings. A 53-year-old woman with a history of hysterectomy for uterine leiomyoma presented with multiple pulmonary nodules and a cystic left breast lesion containing an irregular solid component. Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography demonstrated no significant fluorodeoxyglucose (FDG) uptake in the pulmonary nodules but intense uptake in the cystic lesion of the left breast. Excisional biopsy of the breast revealed an intraductal papilloma, while video-assisted thoracoscopic biopsy of the lung nodules demonstrated benign smooth muscle proliferation positive for α-smooth muscle actin and estrogen receptor (ER), with a very low Ki-67 index, findings consistent with BML. This case illustrates the diagnostic challenge of distinguishing BML from metastatic malignancy in patients with concurrent lesions. Awareness of this entity and its characteristic low FDG uptake may help clinicians avoid unnecessary overtreatment and adopt an appropriate diagnostic strategy.

Indexed as

18f fdg-pet/ctbenign metastasizing leiomyoma (bml)differential diagnosisestrogen receptor (er)multiple pulmonary nodules

Identifiers

PMID41384190
PMCPMC12689469

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.